|
|
|
|
|
|
|
|
|
|
|
30.04.26 - 22:27
|
The Vaccine Safety Signal The Media Still Won′t Read (ZeroHedge)
|
|
|
The Vaccine Safety Signal The Media Still Won't Read
Authored by Dr. Joseph Fraiman via the Brownstone Institute,
The serious-adverse-event signal found in the Pfizer and Moderna mRNA Covid-19 vaccine trials has been in the peer-reviewed literature for nearly four years. Mainstream media outlets, on the rare occasions they address it, have treated it not as evidence to be weighed but as misinformation to be managed - dismissed on the authority of experts without relevant expertise, or simply ignored. A recent BBC Radio 4 broadcast is a near-textbook example.
The broadcast aired on Everything Is Fake and Nobody Cares, a BBC Radio 4 series hosted by Jamie Bartlett, whose stated purpose is to ask why, in so much of modern life, fakery is no longer punished but rewarded. It is a reasonable question. The most direct answer the series has produced to date appears inside one of its own episodes.
In the episode in question, Bartlett devoted his broadcast to Dr. Aseem Malhotra and Covid-19 vaccine saf...
|
|
|
|
|
|
|
|
|
29.04.26 - 14:09
|
Pfizer Aktie: Vyndamax-Deal sorgt für Zweifel an Patentstärke (Aktiencheck)
|
|
|
New York (www.aktiencheck.de) - Pfizer-Aktienanalyse von Morgan Stanley:
Die Analysten von Morgan Stanley bewerten die Aktie von Pfizer Inc. (ISIN: US7170811035, WKN: 852009, Ticker-Symbol: PFE, NYSE-Symbol: PFE) mit einem Rating "equal-weight" und einem Kursziel von 28 USD.
Pfizer habe eine Einigung mit allen drei Generika-Anbietern von Vyndamax erzielt, wodurch die US-Exklusivität des Medikaments bis zum 1. [mehr]...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
